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Carcinogenicity Studies on
Halogenated Hydrocarbons
by Elizabeth K. Weisburger*
A series of halogenated compounds was tested by oral intubation in 200 Osborne-Mendel rats and 200
B6C3F1 mice of both sexes. Carbon tetrachloride, used as a positive control, induced liver and adrenal
tumors in mice and neoplastic nodules in the livers of rats. 1,2-Dibromoethane and 1,2-
dibromo-3-chloropropane caused stomach tumors with many metastases in both rats and mice.
Chloroform, known to cause hepatocellular carcinomas in mice, led in addition to kidney tumors in male
rats. 1,2-Dichloroethane was much weaker than the analog, 1,2-dibromoethane, and induced only a few
stomach tumors in rats. It increased liver and lung tumors in mice. Most of the compounds, namely,
trichloroethylene, 1,1-dichloroethane, 1,1,2-trichloroethane, hexachloroethane, and tetrachloroethylene,
increased hepatocellular carcinomas in mice but had little or no action in rats. lodoform tended to
increase thyroid tumors in male rats and hepatocellular carcinomas in male mice. The action of
3-chloropropene was questionable. No tumors could be attributed to 1,1,1-trichloroethane (methyl-
chloroform).
Introduction
In the 1960's, scientists associated with the
Bioassay Program of NCI realized that although
many halogenated aliphatic compounds had wide-
spread environmental uses, they had not received
adequate chronic toxicity studies. Furthermore, at
that time there were fewer regulations on such sub-
stances since they apparently did not fall in the pro-
vince of the FDA, then almost the sole agency in-
volved with such matters. Therefore when the op-
portunity arose to test chemicals under the contract
system, a study of halogenated compounds with
varied uses was initiated.
Materials and Methods
Chemicals
The chemicals were generally purchased from
laboratory supply houses. Purity of each was
checked by gas chromatography and infrared spec-
troscopy. Gas chromatography-mass spectrometry
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was used to identify any minor components found
in each chemical. In many cases the minor compo-
nents were stabilizers usually added to commercial
formulations.
Animals and Conditions
Osborne-Mendel rats (Battelle Memorial Insti-
tute, Columbus, Ohio) were chosen because previ-
ous studies by FDA scientists (1) and by Reuber
and Glover (2) had shown this strain was sensitive
to various chlorinated compounds such as DDT or
carbon tetrachloride. The B6C3FI mouse, a hybrid
of the C57B11/6 female and C3H/He male (Charles
River, Wilmington, Massachusetts) was selected
because ofprevious extensive use in NCI bioassays
(3). The 35-day-old rats and 25 day-old-mice, as re-
ceived from the suppliers, were quarantined for 10
days and randomly assigned to treatment groups.
Rats were individually housed in wire mesh gal-
vanized steel cages; mice in groups of 10 ofone sex
in polypropylene cages (fitted with filter bonnets)
on Sanichips bedding. Cages for rats were changed
weekly; for mice twice each week. The temperature
range was 20-24°C; air was changed 10-15 times per
hour, while relative humidity was kept in the 45 -
55% range. Feed (Wayne Lab-Blox meal) and water
were freely available.
December 1977 7Acute Study
For each compound single dose range finding
studies were done in two male rats and two female
mice. Up to 10 individual dose levels in corn oil
were given by gavage; the animals were then ob-
served for 14 days. The lowest doses causing death
were selected as the highest level for the 8-week
subchronic study, the primary objective of which
was to determine the maximum tolerated dose
(MTD) for the chronic test. In the subchronic
phase, six groups of five males and five females of
each species were used. Five groups received the
test compound at varying dosages; the remaining
group received the corn oil vehicle only. Dosing
was by gavage, 5 days weekly for 6 weeks. The
weekly weights served as a guide for the dosage
during the next week. After the 6-week dosing
period, the animals were observed an additional 2
weeks to detect delayed toxicity and/or the rate of
recovery. Animals were then killed and a gross ne-
cropsy was done to detect abnormalities.
Chronic Test
Based on the results ofthe subchronic study, two
dose levels of each compound were chosen to be
given lo both sexes of Osborne-Mendel rats and
B6C3F1 mice, in groups of50 animals each, a total
of 400 animals in eight groups. There were also 99
male and 98 female rats, 77 male and 80female mice
as untreated colony controls. Each compound as a
corn-oil solution was administered by gavage under
a hood for 5 consecutive days a week. Carbon tet-
rachloride was administered as a positive control
compound.
The animal weights and food consumption per
cage were obtained weekly for the first 10 weeks
and monthly thereafter. Animals were checked
daily for mortality. In cases where mortality was
high or weight gain was lower than within 10% of
the controls, the dose levels of a compound were
reduced or dosing was on an intermittent schedule
to allow survival. Generally dosing of the animals
was stopped after 78 weeks. After an additional 12
weeks on observation or a total of 90 weeks, the
mice were terminated; at 110 weeks the rats were
killed. A gross necropsy was performed on each
animal that died during the experiment or was killed
at the end. Specified organs* plus any tissue con-
*Brain, pituitary, adrenal, thyroid, parathyroid, trachea,
esophagus, thymus, salivary gland, lymph nodes, heart, nasal
passages, lung, spleen, liver, kidney, stomach, small intestine,
large intestine, pancreas, urinary bladder, prostate or uterus,
seminal vesicles and testis with epididymis or ovary, skin with
mammary gland, muscle, nerve, bone, and bone marrow.
taining visible lesions were fixed in 10% buffered
formalin embedded in Paraplast, and sectioned at
5 ,um for slides. Hematoxylin and eosin staining was
used routinely, but other stains were employed
when needed. Diagnoses of any tumors and other
lesions were coded according to the Systematized
Nomenclature of Pathology (SNOP) ofthe College
of American Pathologists, 1965. Further informa-
tion on the experiments is included in the individual
report on each compound, as well as statistical
analysis of the results.
Results
Compounds
In some compounds small amounts of stabilizers
or other minor impurities were detected, generally
by gas chromatography. Details of the columns,
oven temperature and the like are in the individual
reports. As examples, for trichloroethylene the
main impurity was 1,2-epoxybutane (0.19%) while
in chloroform there was 2% of ethanol, added as a
stabilizer. The 1,1,1-trichloroethane sample con-
tained approximately 3% p-dioxane.
Animal Tests
Based on body weight gains and survival rates
during the acute and subchronic studies, estimated
maximum dose levels.for each compound were
selected (Table 1). In the chronic study, due to
signs of toxicity in some of the groups, the doses
were decreased in order to maintain the animals.
Conversely, if there was no effect on weight gain,
doses were increased. The report for each com-
pound gives the details along with the time-
weighted average dose.
Table 1. Maximum dose level (MTD) for oral intubation
Compound
Trichloroethylene
Chloroform
1,1,I-Trichloroethane
lodoform
1,2-Dibromoethane
1,2-Dibromo-3-chloropropane
1,2-Dichloroethane
I,I-Dichloroethane
1,1,2-Trichloroethane
Hexachloroethane
3-Chloropropene
Tetrachloroethylene
Carbon tetrachloride
Level, mg/kg
Rat Mouse
Male Female Male Female
1000 1000 2400 1800
180 180 300 500
1500 1500 1500 1500
120 60 100 100
40 40 120 120
30 30 260 260
100 100 200 300
900 900 3000 3600
100 100 100 100
500 500 500 500
55 55 200 300
1000 1000 1000 1000
100 150 2500 2500
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cal sites, in comparison with findings in controls,
for each compound are provided in the tables.
Reports have been issued by the Carcinogenesis
Program of NCI on three compounds, trichlo-
roethylene, chloroform, and 1,1 ,1-trichloro-
ethane (methylchloroform, (4-6). The first ofthese,
trichloroethylene, had little or no effect in rats but
hepatocellular carcinomas appeared in mice (Table
2).
As was expected, because of a previous study on
chloroform (7), hepatocellular carcinomas occurred
at a high incidence in both male and female mice
given this compound. On the other hand, rats
showed a different pattern. Kidney tumors were in-
creased in males and thyroid tumors in females
Table 2. Occurrence of tumors from trichloroethylene.
Males Females
Tumor Species Control Low High Control Low High
Reticulum-cell sarcoma, Rat 0 0 0 1 1 1
lymphosarcoma,
malignant lymphoma
Mammary fibroadenoma and 0 0 0 4 5 7
adenocarcinoma
Hemangiosarcoma 1 1 2 0 1 0
Thyroid-follicular adenoma 1 2 1 0 0 1
and adenocarcinoma
Pituitary-chromophobe 0 0 0 4 2 6
adenoma
Metastases 2 0 0 0 0 0
Total tumors 7 8 5 10 14 16
Number of animals 20 50 50 20 48 50
examined
Animals with tumors 5 7 5 7 12 12
Liver-hepatocellular Mouse 1 26 31 0 4 11
carcinoma
Reticulum-cell sarcoma, 1 4 2 1 5 6
lymphosarcoma, malignant
lymphoma
Carcinoma of lung or 0 0 1 0 2 2
alveoli
Adenoma of lung 0 5 1 1 2 5
Metastases 0 4 11 0 0 0
Total tumors 5 41 51 4 19 24
Number of animals 20 50 48 20 50 47
examined
Animals with tumors 5 30 33 4 14 19
Table 3. Occurrence of tumors from chloroform.
Males Females
Tumor Species Control Low High Control Low High
Hepatocellular carcinoma Rat 0 0 1 0 0 0
Kidney-epithelial tumors 0 4 13 0 0 2
Thyroid tumors 4 3 4 1 8 10
Metastases 0 2 5 0 0 5
Total tumors I1 29 29 22 42 37
Number of animals 19 50 50 20 49 48
examined
Animals with tumors 9 24 20 12 24 24
Liver-hepatocellular Mouse 1 19 44 0 36 39
carcinoma
Kidney-epithelial 1 1 2 0 0 0
tumors
Metastases 0 2 4 3 0 2
Total tumors 4 31 58 6 46 42
Number of animals 18 50 45 20 46 41
examined
Animals with tumors 4 26 44 2 37 39
December 1977 9(Table 3). Surprisingly, the analog 1,1,1-tri- had no significant action in mice. However, male
chloroethane had no noticeable effect (Table 4) al- rats at the lower dose level had a slight increase in
though the relatively poor survival of treated ani- thyroid tumors (Table 5). In any event, the renal
mals may have precluded any carcinogenic re- action of chloroform did not hold for the iodo
sponse. Still another chloroform analog, iodoform, analog.
Table 4. Occurrence of tumors from 1,1,1-trichloroethane.
Males Females
Tumor Species Control Low High Control Low High
Liver-hepatocellular Rat 0 0 0 0 0 1
adenoma
Urinary bladder-transitional 0 0 1 0 0 0
cell carcinoma
Pituitary adenoma 0 0 0 3 2 1
Adrenal adenoma and 1 3 1 2 3 2
pheochromocytoma
Thyroid adenomas and 0 0 0 3 0 1
carcinoma
Mammary adenoma and 0 0 1 4 0 1
fibroadenoma
Mammary carcinoma 0 0 0 2 0 1
Metastases 0 0 0 0 0 1
Total tumors 3 6 5 14 7 5
Number of animals 20 49 50 20 50 50
examined
Animals with tumors 3 6 5 7 7 4
Lung-adenoma Mouse I 1 1 0 0 1
Liver-hepatocellular 0 0 4 0 0 0
adenoma and carcinoma
Malignant lymphoma 1 0 2 4 1 0
Metastases 1 0 2 3 0 0
Total tumors 4 2 6 4 2 3
Number of animals 15 47 49 18 48 50
examined
Animals with tumors 2 2 5 3 2 3
Table 5. Occurrence of tumors from iodoform.
Males Females
Tumor Species Control Low High Control Low High
Pituitary adenoma and Rat 4 7 4 5 8 9
carcinoma
Adrenal tumors 1 0 0 0 0 1
Thyroid adenomas and I 11 5 2 5 2
carcinomas
Mammary fibromas or 0 0 0 4 10 8
fibroadenoma
Mammary adenocarcinoma 0 1 1 1 6 4
Kidney tumors 0 0 0 1 0 0
Metastases 5 0 0 0 1 3
Total tumors 12 23 14 17 37 31
Number of animals 20 49 50 20 50 50
examined
Animals with tumors 7 17 10 10 27 23
Lung adenomas and Mouse 1 4 4 1 1 0
carcinomas
Malignant histiocytic 1 2 4 6 2 2
lymphoma
Liver-neoplastic nodule 1 0 0 0 0 0
Liver-hepatocellular 2 5 7 1 1 0
carcinoma
Metastases 0 0 3 0 2 0
Total tumors 5 14 27 10 18 5
Number of animals 19 49 50 20 49 45
examined
Animals with tumors 5 14 23 7 14 5
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1,2-dibromoethane and 1,2-dibromo-3-chloropro-
pane (DBCP) has appeared (8). 1,2-Dibromoethane
led to many squamous cell carcinomas of the
stomach with numerous metastases in rats and mice
(Table 6). In addition to causing stomach carcinomas
with metastases in both rats and mice, DBCP also
caused many mammary tumors in female rats at both
dose levels (Table 7). However, the chloro analog of
1,2-dibromoethane, namely 1,2-dichloroethane, did
not have quite such a potent effect. Some stomach
tumors were present in male rats on the high dose
level. Male mice showed some increase in hepatocel-
lular carcinomas and both males and females on the
high dose level had a definite increase in lung tumors
(Table 8).
Table 6. Occurrence of tumors from 1,2-dibromoethane.
Males Females
Tumor Species Control Low High Control Low High
Stomach-squamous cell Rat 0 49 34 0 41 31
carcinoma
Hemangiosarcoma 0 4 2 0 1 1
Liver-hepatocellular 0 0 0 0 1 5
carcinoma
Metastases 0 30 22 0 38 24
Total tumors 0 55 43 1 43 47
Number of animals 20 50 41 10 42 31
examined
Animals with tumors 0 49 35 1 41 30
Stomach-squamous cell Mouse 0 45 31 0 48 27
carcinoma and papilloma
Liver-hepatocelluilar 1 1 1 0 1 0
carcinoma
Metastases 0 146 126 0 159 62
Total tumors 2 49 36 0 57 34
Number of animals 19 49 48 20 49 50
examined
Animals with tumors 2 45 31 0 48 29
Table 7. Occurrence of tumors from 1, 2-dibromo-3-chloropropane
Males Females
Tumor Species Control Low High Control Low High
Stomach-squamous cell Rat 0 48 48 0 39 38
carcinomas and papillomas
Mammary carcinomas 0 1 1 0 24 30
Hemangiosarcoma 0 13 2 0 8 1
Metastases 0 87 105 0 29 29
Total tumors 1 78 61 4 78 71
Number of animals 20 50 50 20 50 50
examined
Animals with tumors 1 49 47 4 44 43
Stomach-squamous cell Mouse 0 43 47 0 50 47
carcinomas
Liver-hepatocellular 1 1 0 0 0 0
carcinoma
Metastases 0 110 88 0 141 88
Total tumors 2 45 48 0 51 53
Number of animals 19 45 50 20 50 47
examined
Animals with tumors 2 43 47 0 50 47
11 AD'ecember 1977A different structural analog or 1,l-dichlo- (Table 9). Addition of a second chlorine in the
roethane showed practically no effect in rats and led 2-position as in 1,1,2-trichloroethane, afforded a
to only a slight increase in liver tumors in male mice compound with little significant action in rats. How-
Table 8. Occurrence of tumors from 1, 2-dichloroethane.
Males Females
Tumor Species Control Low High Control Low High
Mammary adenocarcinoma Rat 1 2 0 0 0 15
Mammary fibroadenoma 0 0 0 0 14 7
Pituitary adenoma 2 1 4 7 7 5
Hemangiosarcoma 0 12 5 0 5 5
Stomach-squamous cell 0 2 9 0 1 0
carcinoma
Metastases 0 1 7 0 0 2
Total tumors 4 31 39 9 39 47
Number of animals 20 50 50 20 50 50
examined
Animals with tumors 4 20 20 7 24 33
Liver-hepatocellular Mouse 1 6 12 1 0 1
carcinoma
Malignant histiocytic 0 8 5 2 10 2
lymphoma
Lung-adenoma and 0 1 15 1 7 16
carcinoma
Subcutaneous fibrosarcoma 0 0 4 0 0 0
Stomach-squamous cell I 1 2 0 2 5
carcinoma
Metastases I I 1 0 13 13
Total tumors 4 17 40 6 43 43
Number of animals 19 46 47 20 50 48
examined
Animals with tumors 4 15 28 6 33 29
Table 9. Occurrence of tumors from 1, 1-dichloroethane.
Male Female
Tumor Species Control Low High Control Low High
Mammary adenomas Rat 0 0 0 2 6 7
Mammary adenocarcinoma 1 0 0 0 1 5
Pituitary adenoma 1 0 2 2 6 4
Hemangiosarcoma 0 0 1 0 0 4
Metastases 0 5 0 0 1 2
Total tumors 9 6 7 4 17 26
Number of animals 20 50 50 19 50 50
examined
Animals with tumors 6 6 5 4 12 18
Liver-hepatocellular Mouse 1 8 8 1 1 0
carcinoma
Stomach-squamous cell 1 1 0 1 0 0
carcinoma or
papilloma
Malignant histiocytic 0 3 2 2 2 7
lymphoma
Subcutaneous fibrosarcoma 0 3 0 0 0 0
Kidney adenoma 0 3 0 0 0 0
Metastases 1 0 1 0 0 0
Total tumors 4 22 16 7 7 12
Number of animals 19 49 47 20 47 47
examined
Animals with tumors 4 19 15 6 6 12
12 Envirommental Health Perspectivesever, both male and female mice had a decided in- mice (Table 11). Introduction ofa double bond, as in
crease in the number of hepatocellular carcinomas 3-chloropropene, seemed to decrease the
(Table 10). Addition of more chlorine atoms to the hepatomagenic action in mice. Rats were not af-
molecule afforded hexachloroethane which showed a fected significantly (Table 12).
like effect-minimal action in rats, liver tumors in
Table 10. Occurrence of tumors from 1,1,2-trichloroethane.
Males Females
Tumor Species Control Low High Control Low High
Mammary fibroma and Rat 0 0 1 2 18 9
fibroadenoma
Mammary adenocarcinoma I 1 1 0 0 4
Pituitary adenoma 1 5 1 2 9 5
Adrenal adenoma 0 0 1 0 3 1
Thyroid tumors 1 2 0 0 3 1
Hemangiosarcoma 0 4 1 0 1 0
Kidney-hamartoma I 1 0 0 4 1
Metastases 0 1 0 0 0 4
Total tumors 9 26 14 4 50 28
Number of animals 20 50 50 19 50 50
examined
Animals with tumors 6 21 11 4 34 22
Liver-hepatocellular Mouse 2 18 37 0 16 40
carcinoma
Lung adenoma and 0 3 1 0 3 2
carcinoma
Malignant histiocytic 2 7 1 4 4 1
lymphoma
Adrenil-pheochromocytoma 0 0 8 0 0 12
Stomach-squamous cell 0 2 1 0 0 1
carcinoma and
papilloma
Metastaies 0 1 7 0 0 5
Total tumors 6 36 51 5 24 63
Number of animals 20 49 50 20 48 45
examined
Animals with tumors 6 28 38 5 20 41
Table 11. Occurrence of tumors from hexachloroethane.
Males Females
Tumor Species Control Low High Control Low High
Pituitary adenoma and Rat 2 4 0 7 15 7
carcinoma
Adrenal tumors 1 2 0 2 1 1
Thyroid adenomas and 2 3 6 2 5 4
carcinomas
Mammary fibromas and 0 0 0 7 13 10
fibroadenomas
Mammary carcinoma 0 1 0 0 3 1
Kidney tumors 0 5 0 0 1 3
Metastases 4 3 0 1 1 1
Total tumors 13 22 12 22 50 27
Number of animals 20 49 50 20 50 49
examined
Animals with tumors 9 17 11 14 33 20
Lung adenomas and Mouse 0 2 3 1 1 4
carcinomas
Malignant histiocytic 0 0 0 4 9 7
lymphoma
Liver-hepatocellular 3 15 29 2 20 15
carcinoma
Metastases 0 1 0 0 1 0
Total tumors 4 17 37 9 40 30
Number of animals 20 50 49 20 50 49
examined
Animals with tumors 4 17 32 8 32 26
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ethylene, led to similar results as trichloroethyl-
ene in animals. Liver tumors were increased in mice
but there was no significant increase in rats (Table
13).
Table 12. Occurrence of tumors from 3-chloropropene.
Males Females
Tumor Species Control Low High Control Low High
Mammary fibromas and Rat 0 0 0 7 13 4
adenomas
Pituitary tumors 0 1 0 6 6 1
Adrenal-adenoma and 1 1 0 2 0 0
carcinoma
Thyroid tumors 4 6 1 1 2 1
Hemangiosarcoma 2 2 2 0 3 1
Metastases 0 3 0 0 4 4
Total tumors 12 17 4 20 35 18
Number of animals 19 50 50 20 50 50
examined
Animals with tumor 9 15 4 12 26 11
Liver-hepatocellular Mouse 2 8 1 0 1 1
carcinoma
Lung adenoma and 3 6 0 1 5 4
adenocarcinoma
Malignant histiocytic 1 2 2 1 6 7
lymphoma
Stomach-squamous cell 0 2 0 0 3 3
carcinoma and
papilloma
Metastases 0 5 0 0 3 0
Total tumors 6 24 3 4 20 17
Number of animals 20 45 49 19 48 44
examined
Animals with tumor 5 19 3 4 18 15
Table 13. Occurrence of tumors from tetrachloroethylene.
Males Females
Tumor Species Control Low High Control Low High
Mammary adenoma and Rat 0 0 0 3 8 8
fibroadenoma
Mammary adenocarcinoma 0 0 0 1 1 2
Pituitary adenomas 0 1 0 4 9 6
Thyroid adenoma and 1 0 1 0 0 2
carcinoma
Hemangiosarcoma 1 2 1 0 1 0
Metastases 2 0 0 0 7 2
Total tumors 7 5 6 10 25 27
Number of animals 20 49 50 20 50 50
examined
Animals with tumors 5 5 5 7 17 15
Liver-hepatocellular Mouse 2 32 27 0 19 19
carcinoma
Malignant histiocytic 2 0 0 4 0 1
lymphoma
Lung adenoma 0 3 0 0 0 1
Metastases 0 3 0 0 1 1
Total tumors 6 36 28 5 20 21
Number of animals 20 49 47 20 48 48
examined
Animals with tumors 6 33 27 5 19 19
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Males Females
Tumor Species Control Low High Control Low High
Mammary fibroma Rat 0 0 0 4 4 3
Mammary adenocarcinoma 1 2 1 1 1 2
Pituitary tumors 4 5 1 5 7 2
Adrenal tumors I 1 3 0 1 0
Thyroid-adenoma and 1 1 1 2 2 4
carcinoma
Hemangiosarcoma 0 4 4 0 3 1
Liver-neoplastic nodule 0 9 3 1 11 9
Liver-hepatocellular 0 2 2 1 4 2
carcinoma
Metastases 5 2 3 0 0 1
Total tumors 12 29 26 17 46 24
Number of animals 20 49 50 20 50 49
examined
Animals with tumors 7 21 24 10 34 20
Liver-hepatocellular Mouse 3 49 47 1 40 43
carcinoma
Malignant histiocytic 0 2 0 0 0 0
lymphoma
Adrenal adenoma and 0 28 28 0 15 10
pheochromocytoma
Metastases 0 1 0 0 2 1
Total tumors 4 81 75 3 56 54
Number of animals 18 49 48 18 42 45
examined
Animals with tumors 4 49 47 3 40 43
Carbon tetrachloride, used as a positive control,
gave a high yield of hepatocellular carcinomas in
male and female mice, as had been reported earlier
(9). Also of interest was the increase in adrenal
tumors in treated animals. Previous reports have not
mentioned this type of tumor. In the rats, carbon
tetrachloride caused neoplastic nodules and a few
carcinomas ofthe liver. However, the incidence was
lower than was anticipated (Table 14).
Discussion
From the results ofthese experiments, it is evident
that oral administration ofmany halogenated alipha-
tics leads, in many cases, to hepatocellular car-
cinomas in mice and lesser effects in rats. Moreover,
certain of the compounds such as 1,2-di-
bromoethane, DBCP, and chloroform had
other unique carcinogenic actions in rats. It thus
seems that such compounds could pose a hazard to
humans on continued exposure. Of course, humans
are more likely to receive these substances by inhala-
tion, rather than by the oral route. Nevertheless, it
seems prudent, in any environmental situation, to
reduce exposure to such compounds to as low alevel
as is technologically feasible.
The experimental work reported was carried out at Hazleton
Laboratories America, Inc., Vienna, Va., originally under con-
tract NOI-CP-23278 with NCI, and currently under a subcontract
to Tracor-Jitco, Inc.
The secretarial and technical assistance of Frances M. Wil-
liams and Joan Chase is appreciated.
REFERENCES
1. Fitzhugh, 0. G., and Nelson, A. A. The chronic oral toxicity
of DDT (2,2-bis(p-chlorophenyl)- 1,1, 1-trichloroethane).
J. Pharmacol. Exptl. Therap. 89: 18 (1947).
2. Reuber, M. D., and Glover, E. L. Cirrhosis and carcinoma of
the liver in male rats given su.,cutaneous carbon tetra-
chloride. J. Nat. Cancer Inst. 44: 419 (1970).
3. Innes, J. R. M., et al. Bioassay of pesticides and industrial
chemicals for tumorigenicity in mice: a preliminary note. J.
Nat. Cancer Inst. 42: 1101 (1969).
4. National Cancer Institute. Carcinogenesis Bioassay of Tri-
chloroethylene. Carcinogenesis Technical Report Series No.
2, DHEW Publication No. (NIH) 76-802, U. S. Government
Printing Office, Washington, D. C., 1976.
5. National Cancer Institute. Report on Carcinogenesis Bioas-
say ofChloroform. March 1, 1976.
6. National Cancer Institute. Bioassay of 1,1,1-Trichlo-
roethane for Possible Carcinogenicity. Carcinogenesis Tech-
nical Report Series No. 3, DHEW Publication No. (NIH)
77-803, U. S. Government Printing Office, Washington, D.
C., 1976.
December 1977 157. Eschenbrenner, A. B. Induction of hepatomas in mice by
repeated oral administration ofchloroform, with observations
on sex differences. J. Nat. Cancer Inst. 5: 251 (1945).
8. Olson, W. A., et al. Induction of stomach cancer in rats and
mice by halogenated aliphatic fumigants. J. Nat. Cancer Inst.
51: 1993 (1973).
9. Eschenbrenner, A. B., and Miller, E. Liver necrosis and the
induction ofcarbon tetrachloride hepatomas in strain A mice.
J. Nat. Cancer Inst. 6: 325 (1946).
16 Envirommental Health Perspectives